Results 11 to 20 of about 1,528,518 (167)
Clinical Case Reports, 2019 High‐dose‐rate interstitial brachytherapy (HDR‐ISBT) achieved excellent local control of the bulky sebaceous carcinoma of the eyelid. However, we must pay attention to dose of eyelid and cornea about late toxicity of HDR‐ISBT.
Yoshiaki Takagawa +5 more
doaj +1 more source
Out-of-field dose in stereotactic radiotherapy for paediatric patients
Physics and Imaging in Radiation Oncology, 2021 Background and purpose: Stereotactic radiotherapy combines image guidance and high precision delivery with small fields to deliver high doses per fraction in short treatment courses.
Lachlan Garrett +5 more
doaj +1 more source
Frontiers in Oncology, 2019 For patients with unfavorable or high-risk prostate cancer, dose escalated radiation therapy leads to improved progression free survival but attempts to deliver increased dose by external beam radiation therapy (EBRT) alone can be limited by late ...
Benjamin W. Fischer-Valuck +4 more
doaj +1 more source
Optically stimulated luminescent dosimetry for high dose rate brachytherapy
Frontiers in Oncology, 2012 Purpose: The objective was to determine whether optically stimulated luminescent dosimeters (OSLDs) were appropriate for in vivo measurements in high dose rate brachytherapy. In order to make this distinction, three dosimetric characteristics were tested:
Christopher Jason Tien +4 more
doaj +1 more source
Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
Journal of Contemporary Brachytherapy, 2017 Purpose : Salvage treatments for localized radiorecurrent prostate cancer can be performed safely when a focal and image guided approach is used. Due to the low toxicity, the opportunity exists to investigate a second salvage treatment when a second ...
Metha Maenhout +8 more
doaj +1 more source
High-dose-rate interstitial brachytherapy for female peri-urethral cancer
Journal of Contemporary Brachytherapy, 2016 Purpose: Peri-urethral cancer (PUC) in females is a rare malignancy. Surgery is not usually contemplated due to associated morbidity. Radiation therapy (RT) can be employed in the form of interstitial brachytherapy (IBT) alone for early lesions, and ...
Daya Nand Sharma +4 more
doaj +1 more source
Early Toxicities After High Dose Rate Proton Therapy in Cancer Treatments
Frontiers in Oncology, 2021 BackgroundThe conventional dose rate of radiation therapy is 0.01–0.05 Gy per second. According to preclinical studies, an increased dose rate may offer similar anti-tumoral effect while dramatically improving normal tissue protection. This study aims at
Jérôme Doyen +17 more
doaj +1 more source
Modern development of high-dose-rate brachytherapy [PDF]
Japanese Journal of Clinical Oncology, 2020 AbstractBrachytherapy is an invasive therapy with placement of radiation source into or near the tumor. The difference between planning target volume and clinical target volume is minimal, and the dose out of the tumor reduces rapidly due to the inverse-square law.
openaire +2 more sources
Brachytherapy boost in anal canal cancer – A GEC ESTRO PDR task force meta-analysis
Clinical and Translational Radiation Oncology, 2023 Purpose: A meta-analysis is presented comparing clinical outcomes and toxicities between high dose rate (HDR) and pulsed dose rate (PDR) brachytherapy (BT) for anal cancer.
Pierre Annede +7 more
doaj +1 more source
High dose rate brachytherapy for oral cancer [PDF]
Journal of Radiation Research, 2012 Brachytherapy results in better dose distribution compared with other treatments because of steep dose reduction in the surrounding normal tissues. Excellent local control rates and acceptable side effects have been demonstrated with brachytherapy as a sole treatment modality, a postoperative method, and a method of reirradiation.
YamazakI, Hideya +6 more
openaire +2 more sources